(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)boronic acid, 95.0%, 250mg

(2-butyl-4-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol, 98%, 500g

Methyl 1-(4-methylbenzenesulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate, 98%, 10g

Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-[[(4S)-4-hydroxy-4-methyl-2-isoxazolidinyl]carbonyl]-3-methyl-1-(1-methylethyl)-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-, 5mg

2-[(cyclohexylcarbamoyl)amino]acetic acid, 97%, 100mg

2-(1-Hydroxy-3-methylbutylidene)-5,5-dimethyl-1,3-cyclohexanedione>98.0%(GC)1g

5-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

O-(Trimethylsilyl)hydroxylamine>95.0%(GC)25g

4-Cyano-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical>95.0%(T)1g

2-(N-BOC-N-METHYLAMINO)-ACETONITRILE, 93.0%, 1g

Volumetric flasks with glass stopper, class A Clear glass, 200 ml, 14/23, 2 Piece(s)

Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate, 97.0%, 5g

Thiolactic Acid>97.0%(GC)25g